Neural Regeneration Research ›› 2023, Vol. 18 ›› Issue (6): 1321-1324.doi: 10.4103/1673-5374.357907

Previous Articles     Next Articles

A molecular probe carrying anti-tropomyosin 4 for early diagnosis of cerebral ischemia/reperfusion injury

Teng-Fei Yu1, Kun Wang2, Lu Yin1, Wen-Zhe Li3, Chuan-Ping Li4, Wei Zhang1, Jie Tian2, 5, *, Wen He1, *   

  1. 1Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; 2CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China; 3State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China; 4Anhui Province Key Laboratory of Functional Coordinated Complexes for Materials Chemistry and Application, School of Chemical and Environmental Engineering, Anhui Polytechnic University, Wuhu, Anhui Province, China; 5Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, School of Engineering Medicine, Beihang University, Beijing, China
  • Online:2023-06-15 Published:2023-01-05
  • Contact: Wen He, MS, hewen@bjtth.org; Jie Tian, PhD, jie.tian@ia.ac.cn.
  • Supported by:
    This study was supported by the National Natural Science Foundation of China, No. 81730050 (to WH).

Abstract: In vivo imaging of cerebral ischemia/reperfusion injury remains an important challenge. We injected porous Ag/Au@SiO2 bimetallic hollow nanoshells carrying anti-tropomyosin 4 as a molecular probe into mice with cerebral ischemia/reperfusion injury and observed microvascular changes in the brain using photoacoustic imaging with ultrasonography. At each measured time point, the total photoacoustic signal was significantly higher on the affected side than on the healthy side. Twelve hours after reperfusion, cerebral perfusion on the affected side increased, cerebrovascular injury worsened, and anti-tropomyosin 4 expression increased. Twenty-four hours after reperfusion and later, perfusion on the affected side declined slowly and stabilized after 1 week; brain injury was also alleviated. Histopathological and immunohistochemical examinations confirmed the brain injury tissue changes. The nanoshell molecular probe carrying anti-tropomyosin 4 has potential for use in early diagnosis of cerebral ischemia/reperfusion injury and evaluating its progression. 

Key words: cerebral ischemia/reperfusion injury, diagnosis, dynamic monitoring, ischemic stroke, middle cerebral artery occlusion, molecular probe, nanoshells, photoacoustic imaging, tropomyosin 4, ultrasound